Squarepoint’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
VPM
RP
VCM
Squarepoint's ACLS Position: Q1 2026 in Review
Squarepoint reduced its Axcelis (ACLS) stake by 78% in Q1 2026, selling an estimated $10.7M and leaving 33,291 shares worth $3.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1866.
Squarepoint first reported a position in ACLS in Q4 2016 and has held it in 28 quarters since. The position peaked at $12.6M in Q3 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- Squarepoint held 33,291 shares of Axcelis worth $3.1M as of Q1 2026.
- Squarepoint sold 120,412 Axcelis shares in Q1 2026, an estimated $10.7M.
- Axcelis made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #1866 holding.
- Squarepoint first reported a position in Axcelis in Q4 2016 and has held it in 28 quarters since.
- Squarepoint's Axcelis position peaked at $12.6M in Q3 2025.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.